nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadofosveset trisodium—Gastric irritation—Hydrochlorothiazide—nephrolithiasis	0.0579	0.065	CcSEcCtD
Gadofosveset trisodium—Electrolyte imbalance—Hydrochlorothiazide—nephrolithiasis	0.0537	0.0604	CcSEcCtD
Gadofosveset trisodium—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.0481	0.435	CbGpPWpGaD
Gadofosveset trisodium—Epigastric discomfort—Hydrochlorothiazide—nephrolithiasis	0.0427	0.048	CcSEcCtD
Gadofosveset trisodium—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0286	0.0321	CcSEcCtD
Gadofosveset trisodium—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0277	0.0311	CcSEcCtD
Gadofosveset trisodium—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.022	0.0248	CcSEcCtD
Gadofosveset trisodium—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.0212	0.0238	CcSEcCtD
Gadofosveset trisodium—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0192	0.173	CbGpPWpGaD
Gadofosveset trisodium—Swelling—Hydrochlorothiazide—nephrolithiasis	0.0185	0.0207	CcSEcCtD
Gadofosveset trisodium—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0172	0.0193	CcSEcCtD
Gadofosveset trisodium—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0192	CcSEcCtD
Gadofosveset trisodium—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0184	CcSEcCtD
Gadofosveset trisodium—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0163	0.0183	CcSEcCtD
Gadofosveset trisodium—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0171	CcSEcCtD
Gadofosveset trisodium—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0167	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0165	CcSEcCtD
Gadofosveset trisodium—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0165	CcSEcCtD
Gadofosveset trisodium—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0142	0.0159	CcSEcCtD
Gadofosveset trisodium—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.0141	0.0158	CcSEcCtD
Gadofosveset trisodium—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.013	0.0146	CcSEcCtD
Gadofosveset trisodium—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0127	0.0143	CcSEcCtD
Gadofosveset trisodium—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0139	CcSEcCtD
Gadofosveset trisodium—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0139	CcSEcCtD
Gadofosveset trisodium—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0138	CcSEcCtD
Gadofosveset trisodium—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.0122	0.0137	CcSEcCtD
Gadofosveset trisodium—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.012	0.0135	CcSEcCtD
Gadofosveset trisodium—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0129	CcSEcCtD
Gadofosveset trisodium—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0126	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0122	CcSEcCtD
Gadofosveset trisodium—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0118	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0113	CcSEcCtD
Gadofosveset trisodium—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00981	0.011	CcSEcCtD
Gadofosveset trisodium—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00966	0.0109	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0096	0.0108	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00943	0.0106	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00924	0.0104	CcSEcCtD
Gadofosveset trisodium—Tremor—Hydrochlorothiazide—nephrolithiasis	0.00919	0.0103	CcSEcCtD
Gadofosveset trisodium—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00881	0.0099	CcSEcCtD
Gadofosveset trisodium—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00879	0.00989	CcSEcCtD
Gadofosveset trisodium—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00867	0.00974	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00862	0.00969	CcSEcCtD
Gadofosveset trisodium—Cough—Hydrochlorothiazide—nephrolithiasis	0.00856	0.00962	CcSEcCtD
Gadofosveset trisodium—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00835	0.00939	CcSEcCtD
Gadofosveset trisodium—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00832	0.00935	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00816	0.00918	CcSEcCtD
Gadofosveset trisodium—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00807	0.00907	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.008	0.009	CcSEcCtD
Gadofosveset trisodium—Oedema—Hydrochlorothiazide—nephrolithiasis	0.008	0.009	CcSEcCtD
Gadofosveset trisodium—Shock—Hydrochlorothiazide—nephrolithiasis	0.00787	0.00885	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00781	0.00878	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00774	0.0087	CcSEcCtD
Gadofosveset trisodium—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00763	0.00858	CcSEcCtD
Gadofosveset trisodium—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00748	0.00841	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00719	0.00808	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00713	0.00802	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00704	0.00792	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00696	0.00782	CcSEcCtD
Gadofosveset trisodium—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0069	0.00776	CcSEcCtD
Gadofosveset trisodium—Pain—Hydrochlorothiazide—nephrolithiasis	0.00684	0.00769	CcSEcCtD
Gadofosveset trisodium—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00684	0.00769	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00659	0.00741	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00654	0.00736	CcSEcCtD
Gadofosveset trisodium—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00636	0.00715	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00711	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00633	0.00711	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0059	0.00663	CcSEcCtD
Gadofosveset trisodium—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00574	0.00646	CcSEcCtD
Gadofosveset trisodium—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00566	0.00637	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00548	0.00616	CcSEcCtD
Gadofosveset trisodium—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00529	0.00595	CcSEcCtD
Gadofosveset trisodium—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00509	0.00572	CcSEcCtD
Gadofosveset trisodium—Rash—Hydrochlorothiazide—nephrolithiasis	0.00505	0.00567	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00504	0.00567	CcSEcCtD
Gadofosveset trisodium—Headache—Hydrochlorothiazide—nephrolithiasis	0.00501	0.00564	CcSEcCtD
Gadofosveset trisodium—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00475	0.00534	CcSEcCtD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00332	0.03	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00303	0.0274	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00303	0.0274	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.0023	0.0208	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.0023	0.0208	CbGpPWpGaD
Gadofosveset trisodium—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00217	0.0196	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00214	0.0193	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00214	0.0193	CbGpPWpGaD
Gadofosveset trisodium—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.0019	0.0172	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00189	0.0171	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00189	0.0171	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00169	0.0152	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00154	0.0139	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00154	0.0139	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00117	0.0106	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00117	0.0106	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.00112	0.0101	CbGpPWpGaD
Gadofosveset trisodium—ALB—Hemostasis—DGKH—nephrolithiasis	0.00112	0.0101	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00109	0.00982	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00109	0.00982	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000968	0.00876	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000968	0.00876	CbGpPWpGaD
Gadofosveset trisodium—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000774	0.007	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—GRHPR—nephrolithiasis	0.000671	0.00607	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—AGXT—nephrolithiasis	0.000598	0.00541	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—APRT—nephrolithiasis	0.000509	0.0046	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000509	0.0046	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—AQP1—nephrolithiasis	0.000362	0.00328	CbGpPWpGaD
Gadofosveset trisodium—ALB—Metabolism—CHRM3—nephrolithiasis	0.000328	0.00296	CbGpPWpGaD
